Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2026-01-06 @ 4:36 AM
Study NCT ID:
NCT03102034
Status:
COMPLETED
Last Update Posted:
2022-02-08
First Post:
2017-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-06
Start Date Type:
ACTUAL
Primary Completion Date:
2018-05-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-25
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-23
First Submit QC Date:
None
Study First Post Date:
2017-04-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2019-05-23
Results First Submit QC Date:
None
Results First Post Date:
2019-06-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-13
Last Update Post Date:
2022-02-08
Last Update Post Date Type:
ACTUAL